US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ABVC BioPharma, Inc.

2.75

+0.350014.58%

Post-market: 2.800.0500+1.82%19:32 EDT

Volume:320.00K

Turnover:845.76K

Market Cap:44.69M

PE:-12.27

High:2.77

Open:2.39

Low:2.39

Close:2.40

Loading ...

Overview Company News Filings

BRIEF-Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing

ABVC BioPharma files $100M mixed securities shelf

Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD

Press Release: Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

YUKIGUNI FACTORY Reports Impairment Loss Amid Production Challenges

YUKIGUNI FACTORY CO., LTD. Announces Share Buyback Plan

YUKIGUNI FACTORY Reports Financial Variances and Increased Dividends

Yukiguni Maitake Sees FY Net Y2.01B

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan

Cingulate Inc. Receives Buy Rating Amid Promising Developments in ADHD Treatment CTx-1301

Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD

UPDATE: ABVC BioPharma Announces 2024 Financial Results

ABVC BioPharma Determined That It Has A Material Weakness In Its Internal Controls Over Financial Reporting; Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements

Johnson & Johnson says ‘continues to be excited’ about icotrokinra potential

MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)

Hefei Lifeon Pharmaceutical Gets Drug Registration for ADHD Tablets; Shares Soar 10%

MT Newswires Live

ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million

Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABVC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABVC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVC\",,,,,undefined,":{"symbol":"ABVC","market":"US","secType":"STK","nameCN":"ABVC BioPharma, Inc.","latestPrice":2.75,"timestamp":1754078400000,"preClose":2.4,"halted":0,"volume":320002,"hourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.75,"latestTime":"19:32 EDT","volume":178,"amount":495.15,"timestamp":1754091169014},"delay":0,"floatShares":13488792,"shares":16250952,"eps":-0.224214,"marketStatus":"Market Closed","change":0.35,"latestTime":"08-01 16:00:00 EDT","open":2.39,"high":2.77,"low":2.39,"amount":845757.765953,"amplitude":0.158333,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.224214,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"listingDate":1627963200000,"exchange":"NASDAQ","adjPreClose":2.4,"preHourTrading":{"tag":"盘前","latestPrice":2.39,"preClose":2.4,"latestTime":"09:29 EDT","volume":13,"amount":31.2500019,"timestamp":1754054979639},"postHourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.75,"latestTime":"19:32 EDT","volume":178,"amount":495.15,"timestamp":1754091169014},"volumeRatio":1.5342491774483324,"impliedVol":2.1893,"impliedVolPercentile":0.625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABVC\",,,,,undefined,":{"symbol":"ABVC","floatShares":13488792,"roa":"-10.91%","roe":"-42.42%","lyrEps":-0.419983,"volumeRatio":1.5342491774483324,"shares":16250952,"dividePrice":0,"high":2.77,"amplitude":0.158333,"preClose":2.4,"low":2.39,"week52Low":0.4,"pbRate":"8.27","psRate":"87.91","week52High":5.48,"institutionHeld":0,"latestPrice":2.75,"eps":-0.224214,"divideRate":0,"volume":320002,"delay":0,"ttmEps":-0.224214,"open":2.39,"prevYearClose":0.59,"prevWeekClose":3.01,"prevMonthClose":2.4,"prevQuarterClose":2.225,"fiveDayClose":3.01,"twentyDayClose":3.11,"sixtyDayClose":1.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABVC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537922480","title":"BRIEF-Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2537922480","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537922480?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:26","pubTimestamp":1747945598,"startTime":"0","endTime":"0","summary":"BRIEF-Abvc Biopharma Inc Files For Mixed Shelf Of Up To $100 Million - SEC FilingABVC Biopharma Inc ABVC.O:ABVC BIOPHARMA INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILINGSource text: [ID:n0001213900-25-046831]Further company coverage: ABVC.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nFWN3RU0WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2537221609","title":"ABVC BioPharma files $100M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2537221609","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537221609?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:05","pubTimestamp":1747944331,"startTime":"0","endTime":"0","summary":"16:04 EDT ABVC BioPharma (ABVC) files $100M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving bre...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abvc-biopharma-files-100m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abvc-biopharma-files-100m-mixed-securities-shelf-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2536061796","title":"Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2536061796","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536061796?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:00","pubTimestamp":1747742400,"startTime":"0","endTime":"0","summary":"Subjects Demonstrated Marked Improvement of ADHD Symptoms at Week 5New Drug Application on Schedule for this Summer CING CEO Shares Insights and Strategic Outlook on “Unboxing Biotech” Podcast  KANSAS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/05/20/3084809/0/en/Efficacy-Results-Announced-from-Cingulate-s-Phase-3-Pediatric-Study-of-CTx-1301-dexmethylphenidate-for-ADHD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0054578231.USD","CING","BK4139","LU0053671581.USD","ITT","ADHD","BK4161","ABVC","BK4007"],"gpt_icon":0},{"id":"2535007372","title":"Press Release: Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007372","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535007372?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:10","pubTimestamp":1747253400,"startTime":"0","endTime":"0","summary":"-- Phase 2 proof-of-concept trials remain on track: Topline data expected from ALTO-203 in MDD in the second quarter of 2025 followed by ALTO-101 in schizophrenia in the second half of 2025 --. -- Late-stage programs advancing: Topline data expected from the Phase 2b trial of ALTO-300 in MDD in mid-2026 followed by the Phase 2b trial of ALTO-100 in bipolar depression in the second half of 2026 --. -- New data presented at recent scientific conferences support Alto's biomarker-driven pipeline and patient stratification approach --. -- Strong cash position of approximately $161.3 million expected to fund planned operations into 2028, and through at least four upcoming clinical study readouts --. 2026. The Company expects to enroll approximately 200 patients with BPD.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","ANRO","BK4139","LFT","ABVC","BK4007"],"gpt_icon":0},{"id":"2534343226","title":"Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2534343226","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534343226?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:08","pubTimestamp":1747048080,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals is diversifying its already strong lineup of medicines.Axsome Therapeutics has multiple clinical and regulatory catalysts on the way.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/12/prediction-these-2-stocks-will-outperform-the-mark/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0234570918.USD","LU1430594728.SGD","BK4139","LU1069344957.HKD","LU2237438978.USD","IE00B19Z3581.USD","SG9999001176.USD","IE00B19Z3B42.SGD","LU0566484027.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","BK4585","LU0061475181.USD","LU2456880835.USD","LU0757428866.USD","LU0889565916.HKD","LU2362540622.SGD","BK4588","IE00BJT1NW94.SGD","LU2236285917.USD","LU0320765992.SGD","VRTX","LU1815336091.USD","IE00BJJMRZ35.SGD","LU2417539215.USD","IE0002141913.USD","BK4532","IE00B19Z9P08.USD","LU0823416689.USD","LU2324357040.USD","LU1585245621.USD","BK4567","BK4533","LU0079474960.USD","IE00B894F039.SGD","LU0109394709.USD","LU1035775433.USD","IE00B4R5TH58.HKD","LU2362541273.HKD","LU0417517546.SGD","SG9999013999.USD","LU1093756168.USD","IE0009355771.USD","IE00B19Z9Z06.USD","BK4093","LU1093756325.SGD","VERX","CF","ABVC","LU0256863811.USD"],"gpt_icon":0},{"id":"2534232129","title":"YUKIGUNI FACTORY Reports Impairment Loss Amid Production Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2534232129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534232129?lang=en_us&edition=fundamental","pubTime":"2025-05-09 15:14","pubTimestamp":1746774858,"startTime":"0","endTime":"0","summary":"An update from YUKIGUNI MAITAKE CO., LTD. ( ($JP:1375) ) is now available. YUKIGUNI FACTORY CO., LTD. has announced an impairment loss due to decre...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yukiguni-factory-reports-impairment-loss-amid-production-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yukiguni-factory-reports-impairment-loss-amid-production-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2534292131","title":"YUKIGUNI FACTORY CO., LTD. Announces Share Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2534292131","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534292131?lang=en_us&edition=fundamental","pubTime":"2025-05-09 15:14","pubTimestamp":1746774848,"startTime":"0","endTime":"0","summary":"YUKIGUNI MAITAKE CO., LTD. ( ($JP:1375) ) has shared an update. YUKIGUNI FACTORY CO., LTD. has announced its decision to acquire its own shares as ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yukiguni-factory-co-ltd-announces-share-buyback-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yukiguni-factory-co-ltd-announces-share-buyback-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2534129429","title":"YUKIGUNI FACTORY Reports Financial Variances and Increased Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2534129429","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534129429?lang=en_us&edition=fundamental","pubTime":"2025-05-09 15:13","pubTimestamp":1746774834,"startTime":"0","endTime":"0","summary":"An announcement from YUKIGUNI MAITAKE CO., LTD. ( ($JP:1375) ) is now available. YUKIGUNI FACTORY CO., LTD., a company listed on the Tokyo Stock Ex...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yukiguni-factory-reports-financial-variances-and-increased-dividends?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yukiguni-factory-reports-financial-variances-and-increased-dividends?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2534128196","title":"Yukiguni Maitake Sees FY Net Y2.01B","url":"https://stock-news.laohu8.com/highlight/detail?id=2534128196","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534128196?lang=en_us&edition=fundamental","pubTime":"2025-05-09 14:31","pubTimestamp":1746772260,"startTime":"0","endTime":"0","summary":"Yukiguni Maitake Co. Ltd. also released the following forecasts: GROUPYear Ending Mar 2026 Operating ProfitY3.27 bln Pretax ProfitY3.07 bln Net ProfitY2.01 bln Per share EarningsY50.39 Results are based on IFRS accounting standards.This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC"],"gpt_icon":0},{"id":"2533565074","title":"Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533565074","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533565074?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:30","pubTimestamp":1746477000,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., May 05, 2025  -- Neuronetics, Inc. , a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards of Restricted Stock Units representing a total of 4,500 shares of the Company’s common stock  to three new non-executive employees. In accordance with NASDAQ Listing Rule 5635, these awards were approved by Neuronetics’ Compensation Committee and made as material inducements to their respective employment with the Company.The RSU grants vest ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient’s continued service with the Company through the applicable vesting date. The RSUs are subject to the terms of the Neuronetics 2020 Inducement Plan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neuronetics-reports-inducement-grant-under-203000325.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","STIM","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","BK4139","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4588","LU2210149790.SGD","IE00BKPKM429.USD",".IXIC","BK4082","ABVC","BK4585"],"gpt_icon":0},{"id":"2532777220","title":"ABVC BioPharma Announces First Quarter 2025 Financial Results and Strategic Planning for AI-Driven Agricultural Project in Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2532777220","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532777220?lang=en_us&edition=fundamental","pubTime":"2025-05-01 20:30","pubTimestamp":1746102600,"startTime":"0","endTime":"0","summary":"SILICON VALLEY, CA - May 1, 2025  - ABVC BioPharma, Inc. , a clinical-stage biopharmaceutical company developing botanical-based therapies for central nervous system, oncology, and ophthalmology indications, today announced its financial results for the first quarter ended March 31, 2025, and shared updates on its strategic plan to explore the development of an AI-enabled agricultural facility in Taiwan.Recognized a land asset in Taiwan valued at $7,670,000, for which the Company is evaluating development of a GAP-compliant, AI-powered plant factory. In the first quarter of 2025, ABVC recognized a parcel of land in central Taiwan valued at $7,670,000 as a strategic asset. The Company is currently assessing the feasibility of developing this site into a state-of-the-art, AI-integrated agricultural facility designed to meet Good Agricultural Practices  standards. There can be no assurance that the project will be implemented as currently envisioned, or that any future development on the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvc-biopharma-announces-first-quarter-123000753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4094","ABVC","BK4232","GAP","BK4022","BK4139","R"],"gpt_icon":0},{"id":"2531776052","title":"Cingulate Inc. Receives Buy Rating Amid Promising Developments in ADHD Treatment CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2531776052","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531776052?lang=en_us&edition=fundamental","pubTime":"2025-04-30 23:15","pubTimestamp":1746026142,"startTime":"0","endTime":"0","summary":"Naz Rahman, an analyst from Maxim Group, reiterated the Buy rating on Cingulate Inc (CING – Research Report). The associated price target remains t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/cingulate-inc-receives-buy-rating-amid-promising-developments-in-adhd-treatment-ctx-1301?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/cingulate-inc-receives-buy-rating-amid-promising-developments-in-adhd-treatment-ctx-1301?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADHD","ABVC","CING"],"gpt_icon":0},{"id":"2531733589","title":"Cingulate Announces Positive Top-Line Results from High-Dose (50mg) Fed/Fast Study of Lead Asset CTx-1301 for ADHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2531733589","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531733589?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":"Primary Endpoints Demonstrate CTx-1301 Can be Taken With or Without Food. CTx-1301 is Designed as a True, Entire Active-Day Treatment for ADHD. The trial demonstrated that 50mg CTx-1301 can be taken with or without food. Multiple pharmacokinetic  measurements were taken, and adverse events were consistent with previous findings and indicate a favorable tolerability profile.“Similar to the 25mg fasted versus fed study conducted with CTx-1301 , the 50mg dose of CTx-1301 demonstrated that it may also be taken with or without food, however patients should be advised to take the medication consistently as such,\" said Raul Silva, MD, Chief Science Officer, Cingulate. “Most importantly is that the unique formulation of CTx-1301 is bi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cingulate-announces-positive-top-line-120000878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4585","ADHD","BK4104","US6M.BOND","US30Y.BOND","BK4218","FAST","CINGW","BK4181","US3Y.BOND","IE00BYQQ9H92.USD","BK4007","IE00B5TLWC47.USD","US5Y.BOND","US7Y.BOND","CING","BK4139","BK4567","IE00BFXG0V08.USD","ABVC","US10Y.BOND","PK","US2Y.BOND","US12M.BOND"],"gpt_icon":0},{"id":"2527621023","title":"UPDATE: ABVC BioPharma Announces 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2527621023","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527621023?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:00","pubTimestamp":1744808400,"startTime":"0","endTime":"0","summary":"Revenue Surges 234%, Expenses Down 21%, EPS Improves 77%, with Over $18.3 Million Licensing Incomes Available. Revenue Growth of 234% Fueled by Global Licensing Milestones. ABVC reported total revenues of $509,589 in 2024, representing a 234% increase compared to $152,430 in 2023. This significant growth was primarily driven by milestone payments collected from the Company's global licensing partners in CNS, oncology, and ophthalmology therapeutic areas.Importantly, ABVC remains eligible to receive up to an additional $18.3 million in milestone payments under existing licensing agreements, which, if received, will provide strong non-dilutive funding visibility to support future growth.Operating Expenses Reduced by 21% Reflecting Cost Discipline. Total operating expenses were reduced to $5.21 million in 2024, down 21% from $6.62 million in 2023. The decline was primarily driven by:. Selling, General and Administrative expenses reduced by 58%. \"2024 was a breakthrough year for ABVC. We d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvc-biopharma-announces-2024-financial-130000454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4022","BK4232","R","ABVC","BK4139"],"gpt_icon":0},{"id":"2527747836","title":"ABVC BioPharma Determined That It Has A Material Weakness In Its Internal Controls Over Financial Reporting; Concluded That Financial Statements For FY Ended Dec 31, 2023 Should No Longer Be Relied Upon Due To Errors In Financial Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2527747836","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527747836?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:43","pubTimestamp":1744749806,"startTime":"0","endTime":"0","summary":"- SEC Filing","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/04/44826993/abvc-biopharma-determined-that-it-has-a-material-weakness-in-its-internal-controls-over-financial-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2527533419","title":"Johnson & Johnson says ‘continues to be excited’ about icotrokinra potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2527533419","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527533419?lang=en_us&edition=fundamental","pubTime":"2025-04-15 20:50","pubTimestamp":1744721412,"startTime":"0","endTime":"0","summary":"Says anticipates potential approval for CAPLYTA as adjunctive treatment for MDD later this year. Says plans to file for icotrokinra approval later ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-continues-to-be-excited-about-icotrokinra-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-says-continues-to-be-excited-about-icotrokinra-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","IE00BDGV0183.EUR","BK4592","LU1221951046.USD","LU1066051225.USD","LU0203347892.USD","LU1280957306.USD","BK4585","LU0114720955.EUR","IE0002270589.USD","LU1778281490.HKD","LU2089984988.USD","IE00B4R5TH58.HKD","LU0320765646.SGD","BK4139","IE0034235303.USD","LU2430703095.HKD","LU1914381329.SGD","BK4533","IE00B19Z3581.USD","IE00B3PB1722.GBP","IE00BN8TJ469.HKD","LU1261432733.SGD","LU0795875086.SGD","IE00BSNM7G36.USD","LU1935042991.SGD","LU0795875169.SGD","IE00BFTCPJ56.SGD","LU2129689514.USD","LU0912757837.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1162221912.USD","LU1674673691.USD","LU1244550577.SGD","LU1267930813.SGD","IE0002141913.USD","ABVC","LU1929549753.HKD","LU1066053197.SGD","LU0889566641.SGD","LU1430594728.SGD","LU1196500208.SGD","LU0640476718.USD","LU1506573853.SGD","LU1032955483.USD","JNJ","LU2505996509.AUD","IE00B1BXHZ80.USD","LU0203345920.USD"],"gpt_icon":0},{"id":"2527541636","title":"MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527541636","media":"Business Wire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527541636?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714800,"startTime":"0","endTime":"0","summary":"- Emerge is the first Phase 3 study of lysergide D-tartrate  in MDD; primary endpoint will measure change from baseline in Montgomery-sberg Depression Rating Scale  score at Week 6 between MM120 Orally Disintegrating Tablet  100 g and placebo -. - Topline data from the 12-week double-blind period anticipated in the second half of 2026 -. \"In our Phase 2b study, MADRS score improvements after a single MM120 100 g dose were clinically and statistically significant compared to placebo, providing meaningful benefits to participants. Having dosed the first participant in the Phase 3 Emerge study, we are excited for the therapeutic potential that MM120 ODT shows for the 21 million people in the U.S. affected by MDD,\" said Daniel R. Karlin, M.D., M.A., Chief Medical Officer of MindMed. \"By running our MDD and GAD Phase 3 studies concurrently, we can leverage the shared symptomatology between these conditions to more effectively match participants to the appropriate study based on their clinic","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mindmed-announces-first-patient-dosed-110000855.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4547","ODT","ABVC","BK4139","MNMD"],"gpt_icon":0},{"id":"2527843036","title":"Hefei Lifeon Pharmaceutical Gets Drug Registration for ADHD Tablets; Shares Soar 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527843036","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527843036?lang=en_us&edition=fundamental","pubTime":"2025-04-15 14:35","pubTimestamp":1744698915,"startTime":"0","endTime":"0","summary":"Hefei Lifeon Pharmaceutical  obtained drug registration from China's drug administrator for its methylphenidate hydrochloride extended-release tablets.The drug is a first-class psychotropic substance mainly used to treat attention deficit hyperactivity disorder, according to a Tuesday filing with the Shenzhen bourse.Shares of the pharmaceutical company rose 10% in recent trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","003020","BK0250","ABVC","ADHD"],"gpt_icon":0},{"id":"2524693257","title":"ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2524693257","media":"NewMediaWire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524693257?lang=en_us&edition=fundamental","pubTime":"2025-04-03 21:00","pubTimestamp":1743685200,"startTime":"0","endTime":"0","summary":"The acquired land will be designated for the cultivation and extraction of Polygala tenuifolia , a central ingredient in AiBtl's botanical drug candidates for Major Depressive Disorder  and Attention Deficit Hyperactivity Disorder . The Company believes this move is key to reducing sourcing risk and supporting large-scale, high-quality production of active botanical compounds.\"This agreement is a long-term investment into securing the future of botanical drug innovation,\" said Uttam Patil, Ph.D., Chief Executive Officer of ABVC. \"By locking in upstream resources in Asia, we are strengthening AiBtl's infrastructure from seed to formulation - giving our neuroscience pipeline a sustainable foundation.\". The transaction also reflects ABVC's continuing efforts to expand its physical and operational footprint in the Asia-Pacific region while enhancing value for global shareholders.ADHD Drug Candidate: The ADHD market is expected to exceed $24 billion by 2032, fueled by increasing diagnoses a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/abvcs-subsidiary-aibtl-signs-share-130000720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADHD","ABVC","BK4232","BK4022","BK4139","R","USD"],"gpt_icon":0},{"id":"2524184251","title":"Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301","url":"https://stock-news.laohu8.com/highlight/detail?id=2524184251","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524184251?lang=en_us&edition=fundamental","pubTime":"2025-04-03 20:00","pubTimestamp":1743681600,"startTime":"0","endTime":"0","summary":"“Our meeting with the FDA yesterday was very productive, and we remain on track for an NDA filing of CTx-1301 in mid-2025. We truly appreciate the FDA personnel who have been involved with the regulatory review of CTx-1301 to date. These interactions have been essential in helping us generate data to demonstrate the consistency and therapeutic benefit of our product. This important milestone is validation of our mission to bring to market the first, true, once-daily stimulant medication to treat ADHD over the entire active day,” said Cingulate Chairman and CEO Shane J Schaffer.About CTx-1301Cingulate’s lead candidate, CTx-1301, utilizes Cingulate’s proprietary PTR drug delivery platform to create a breakthrough, multi-core formulation of the active pharmaceutical ingredient dexmethylphenidate, a compound approved by the FDA for the treatment of ADHD. Dexmethylphenidate is part of the stimulant class of medicines and increases norepinephrine and dopamine activity in the brain to affect ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cingulate-completes-pre-nda-meeting-120000674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CINGW","BK4139","BK4007","CING","ADHD","ABVC"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":75,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABVC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-30","symbol":"ABVC","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-04-15","symbol":"ABVC","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"post","actualEps":0.04},{"market":"US","date":"2024-11-14","symbol":"ABVC","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.02},{"market":"US","date":"2024-08-14","symbol":"ABVC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"","actualEps":-0.09},{"market":"US","date":"2024-05-17","symbol":"ABVC","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715918400000,"reportTimeType":"post","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABVC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABVC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABVC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABVC","date":"2025-08-01","current":-13.399375,"percent":0.151909,"low":-26.463766,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"high":-0.260274,"avg":-5.529761,"sd":5.973523,"marketCap":39002284},"quantilePoints":[{"date":"2020-08-07","current":-17.817247,"twenty":-104.984049,"median":-60.422571,"eighty":-15.816469,"marketCap":73008719},{"date":"2020-08-14","current":-14.118204,"twenty":-104.984049,"median":-58.912006,"eighty":-15.816469,"marketCap":76088142},{"date":"2020-08-21","current":-14.296916,"twenty":-104.984049,"median":-47.962314,"eighty":-15.601069,"marketCap":77051284},{"date":"2020-08-28","current":-12.867224,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":69346155},{"date":"2020-09-04","current":-14.296916,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":77051284},{"date":"2020-09-11","current":-14.118204,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":76088142},{"date":"2020-09-18","current":-14.296916,"twenty":-104.984049,"median":-47.962314,"eighty":-15.563236,"marketCap":77051284},{"date":"2020-09-25","current":-14.118204,"twenty":-104.984049,"median":-47.962314,"eighty":-15.299453,"marketCap":76088142},{"date":"2020-10-02","current":-14.654339,"twenty":-104.984049,"median":-47.962314,"eighty":-14.943492,"marketCap":78977566},{"date":"2020-10-09","current":-14.887513,"twenty":-104.984049,"median":-47.962314,"eighty":-14.873601,"marketCap":80234224},{"date":"2020-10-16","current":-15.910707,"twenty":-104.984049,"median":-47.962314,"eighty":-14.887513,"marketCap":85748593},{"date":"2020-10-23","current":-15.522641,"twenty":-104.984049,"median":-47.962314,"eighty":-14.957404,"marketCap":83657164},{"date":"2020-10-30","current":-15.134575,"twenty":-104.984049,"median":-46.033619,"eighty":-15.082344,"marketCap":81565734},{"date":"2020-11-06","current":-15.199238,"twenty":-104.984049,"median":-46.033619,"eighty":-15.134575,"marketCap":81914224},{"date":"2020-11-13","current":-15.009247,"twenty":-104.984049,"median":-43.698955,"eighty":-14.957404,"marketCap":80890296},{"date":"2020-11-20","current":-13.64563,"twenty":-104.984049,"median":-39.895803,"eighty":-14.839343,"marketCap":82154224},{"date":"2020-11-27","current":-14.327911,"twenty":-104.984049,"median":-39.895803,"eighty":-14.654339,"marketCap":86261935},{"date":"2020-12-04","current":-14.498482,"twenty":-104.984049,"median":-39.895803,"eighty":-14.484769,"marketCap":87288863},{"date":"2020-12-11","current":-15.351334,"twenty":-104.984049,"median":-38.369814,"eighty":-14.475627,"marketCap":92423502},{"date":"2020-12-18","current":-17.057037,"twenty":-104.984049,"median":-37.594122,"eighty":-14.484769,"marketCap":102692780},{"date":"2020-12-24","current":-17.739319,"twenty":-104.984049,"median":-36.826895,"eighty":-14.498482,"marketCap":106800491},{"date":"2020-12-31","current":-17.398178,"twenty":-104.984049,"median":-36.826895,"eighty":-14.498482,"marketCap":104746635},{"date":"2021-01-08","current":-20.052297,"twenty":-104.984049,"median":-36.67345,"eighty":-14.549617,"marketCap":120725895},{"date":"2021-01-15","current":-21.65648,"twenty":-104.984049,"median":-34.580924,"eighty":-14.654339,"marketCap":130383966},{"date":"2021-01-22","current":-21.255434,"twenty":-104.984049,"median":-33.757987,"eighty":-14.654339,"marketCap":127969448},{"date":"2021-01-29","current":-20.052297,"twenty":-104.984049,"median":-33.757987,"eighty":-14.666109,"marketCap":120725895},{"date":"2021-02-05","current":-19.851774,"twenty":-104.984049,"median":-33.757987,"eighty":-14.751318,"marketCap":119518636},{"date":"2021-02-12","current":-19.450728,"twenty":-104.984049,"median":-32.897231,"eighty":-14.809783,"marketCap":117104118},{"date":"2021-02-19","current":-20.052297,"twenty":-104.984049,"median":-32.897231,"eighty":-14.839343,"marketCap":120725895},{"date":"2021-02-26","current":-17.646021,"twenty":-104.984049,"median":-32.530424,"eighty":-14.873601,"marketCap":106238787},{"date":"2021-03-05","current":-17.646021,"twenty":-104.984049,"median":-31.609752,"eighty":-14.887513,"marketCap":106238787},{"date":"2021-03-12","current":-18.047067,"twenty":-104.984049,"median":-30.689079,"eighty":-14.920184,"marketCap":108653305},{"date":"2021-03-19","current":-10.850476,"twenty":-104.984049,"median":-30.689079,"eighty":-14.839343,"marketCap":106238787},{"date":"2021-03-26","current":-10.973777,"twenty":-104.984049,"median":-30.437981,"eighty":-14.654339,"marketCap":107446046},{"date":"2021-04-01","current":-11.097077,"twenty":-104.984049,"median":-30.103498,"eighty":-14.498482,"marketCap":108653305},{"date":"2021-04-09","current":-10.850476,"twenty":-104.984049,"median":-30.103498,"eighty":-14.386997,"marketCap":106238787},{"date":"2021-04-16","current":-10.850476,"twenty":-104.984049,"median":-29.613533,"eighty":-14.327911,"marketCap":106238787},{"date":"2021-04-23","current":-11.097077,"twenty":-104.984049,"median":-28.765565,"eighty":-14.296916,"marketCap":108653305},{"date":"2021-04-30","current":-11.097077,"twenty":-104.984049,"median":-28.224507,"eighty":-14.296916,"marketCap":108653305},{"date":"2021-05-07","current":-11.46698,"twenty":-104.984049,"median":-28.224507,"eighty":-14.296916,"marketCap":112275082},{"date":"2021-05-14","current":-13.730013,"twenty":-104.984049,"median":-27.28369,"eighty":-14.296916,"marketCap":132798484},{"date":"2021-05-21","current":-13.730013,"twenty":-104.984049,"median":-26.65832,"eighty":-14.296916,"marketCap":132798484},{"date":"2021-05-28","current":-13.730013,"twenty":-103.326706,"median":-26.132665,"eighty":-14.118204,"marketCap":132798484},{"date":"2021-06-04","current":-13.355558,"twenty":-100.840692,"median":-25.838836,"eighty":-14.118204,"marketCap":129176707},{"date":"2021-06-11","current":-12.981103,"twenty":-100.840692,"median":-25.62158,"eighty":-14.066248,"marketCap":125554930},{"date":"2021-06-18","current":-11.857738,"twenty":-100.840692,"median":-25.489795,"eighty":-14.066248,"marketCap":114689600},{"date":"2021-06-25","current":-12.48183,"twenty":-100.840692,"median":-23.923098,"eighty":-13.947524,"marketCap":120725895},{"date":"2021-07-02","current":-11.233647,"twenty":-100.840692,"median":-23.282,"eighty":-13.770344,"marketCap":108653305},{"date":"2021-07-09","current":-12.48183,"twenty":-100.840692,"median":-22.944579,"eighty":-13.730013,"marketCap":120725895},{"date":"2021-07-16","current":-12.48183,"twenty":-100.840692,"median":-22.775869,"eighty":-13.730013,"marketCap":120725895},{"date":"2021-07-23","current":-12.357012,"twenty":-100.840692,"median":-22.633127,"eighty":-13.64563,"marketCap":119518636},{"date":"2021-07-30","current":-12.357585,"twenty":-100.840692,"median":-22.438449,"eighty":-13.64563,"marketCap":119524184},{"date":"2021-08-06","current":-8.290388,"twenty":-100.840692,"median":-22.020758,"eighty":-13.355558,"marketCap":80185717},{"date":"2021-08-13","current":-5.99167,"twenty":-100.840692,"median":-21.65648,"eighty":-13.337149,"marketCap":58684815},{"date":"2021-08-20","current":-5.242711,"twenty":-100.840692,"median":-21.054911,"eighty":-13.23074,"marketCap":51349213},{"date":"2021-08-27","current":-7.670371,"twenty":-100.840692,"median":-20.611957,"eighty":-13.105921,"marketCap":75126681},{"date":"2021-09-03","current":-8.393504,"twenty":-100.840692,"median":-20.536178,"eighty":-12.981103,"marketCap":82209331},{"date":"2021-09-10","current":-8.290199,"twenty":-100.840692,"median":-20.327641,"eighty":-12.731467,"marketCap":81197524},{"date":"2021-09-17","current":-7.386283,"twenty":-100.840692,"median":-20.25282,"eighty":-12.48183,"marketCap":72344211},{"date":"2021-09-24","current":-6.404889,"twenty":-100.840692,"median":-20.249018,"eighty":-12.48183,"marketCap":62732043},{"date":"2021-10-01","current":-5.862539,"twenty":-100.840692,"median":-20.143991,"eighty":-12.48183,"marketCap":57420056},{"date":"2021-10-08","current":-5.578452,"twenty":-96.807064,"median":-20.052297,"eighty":-12.48183,"marketCap":54637586},{"date":"2021-10-15","current":-6.998891,"twenty":-95.798657,"median":-20.052297,"eighty":-12.48183,"marketCap":68549935},{"date":"2021-10-22","current":-6.379063,"twenty":-95.798657,"median":-20.02901,"eighty":-12.357012,"marketCap":62479092},{"date":"2021-10-29","current":-6.885086,"twenty":-95.798657,"median":-20.005723,"eighty":-12.332048,"marketCap":67435282},{"date":"2021-11-05","current":-10.164989,"twenty":-93.770452,"median":-19.95676,"eighty":-12.112235,"marketCap":99559965},{"date":"2021-11-12","current":-8.999403,"twenty":-93.263401,"median":-19.851774,"eighty":-11.72383,"marketCap":88143755},{"date":"2021-11-19","current":-9.556177,"twenty":-93.263401,"median":-19.851774,"eighty":-11.230993,"marketCap":93218994},{"date":"2021-11-26","current":-9.294762,"twenty":-93.263401,"median":-19.851774,"eighty":-11.139591,"marketCap":90668931},{"date":"2021-12-03","current":-8.510516,"twenty":-93.263401,"median":-19.450728,"eighty":-11.097077,"marketCap":83018740},{"date":"2021-12-10","current":-10.108053,"twenty":-90.465498,"median":-19.450728,"eighty":-11.097077,"marketCap":98602462},{"date":"2021-12-17","current":-10.398515,"twenty":-88.60023,"median":-19.450728,"eighty":-11.097077,"marketCap":101435866},{"date":"2021-12-23","current":-10.950391,"twenty":-88.60023,"median":-19.250205,"eighty":-11.042884,"marketCap":106819334},{"date":"2021-12-31","current":-9.846638,"twenty":-88.60023,"median":-18.803806,"eighty":-10.973777,"marketCap":96052398},{"date":"2022-01-07","current":-9.90473,"twenty":-88.60023,"median":-18.754997,"eighty":-10.850476,"marketCap":96619079},{"date":"2022-01-14","current":-9.556177,"twenty":-88.60023,"median":-18.687731,"eighty":-10.850476,"marketCap":93218994},{"date":"2022-01-21","current":-7.900547,"twenty":-88.60023,"median":-18.539338,"eighty":-10.850476,"marketCap":77068591},{"date":"2022-01-28","current":-7.174394,"twenty":-88.60023,"median":-18.52056,"eighty":-10.712213,"marketCap":69985081},{"date":"2022-02-04","current":-7.319625,"twenty":-88.60023,"median":-18.401426,"eighty":-10.554554,"marketCap":71401783},{"date":"2022-02-11","current":-7.668178,"twenty":-88.60023,"median":-18.286122,"eighty":-10.404324,"marketCap":74801868},{"date":"2022-02-18","current":-7.348671,"twenty":-88.60023,"median":-18.220695,"eighty":-10.343792,"marketCap":71685123},{"date":"2022-02-25","current":-7.116302,"twenty":-88.60023,"median":-18.188702,"eighty":-10.164989,"marketCap":69418400},{"date":"2022-03-04","current":-7.116302,"twenty":-88.60023,"median":-18.047067,"eighty":-9.98737,"marketCap":69418400},{"date":"2022-03-11","current":-6.622518,"twenty":-88.60023,"median":-18.047067,"eighty":-9.875684,"marketCap":64601613},{"date":"2022-03-18","current":-6.564425,"twenty":-88.60023,"median":-17.909889,"eighty":-9.788546,"marketCap":64034932},{"date":"2022-03-25","current":-7.029163,"twenty":-88.60023,"median":-17.850261,"eighty":-9.704796,"marketCap":68568379},{"date":"2022-04-01","current":-6.339112,"twenty":-88.60023,"median":-17.739319,"eighty":-9.704796,"marketCap":81386671},{"date":"2022-04-08","current":-6.31572,"twenty":-88.60023,"median":-17.732346,"eighty":-9.704796,"marketCap":81086351},{"date":"2022-04-14","current":-5.894672,"twenty":-88.60023,"median":-17.680293,"eighty":-9.60846,"marketCap":75680594},{"date":"2022-04-22","current":-5.754323,"twenty":-88.60023,"median":-17.646021,"eighty":-9.54452,"marketCap":73878675},{"date":"2022-04-29","current":-5.590582,"twenty":-88.60023,"median":-17.646021,"eighty":-9.360688,"marketCap":71776436},{"date":"2022-05-06","current":-5.766019,"twenty":-88.60023,"median":-17.646021,"eighty":-9.252091,"marketCap":74028835},{"date":"2022-05-13","current":-5.2631,"twenty":-88.60023,"median":-17.58281,"eighty":-9.119715,"marketCap":67571959},{"date":"2022-05-20","current":-3.799171,"twenty":-88.60023,"median":-17.545855,"eighty":-9.098246,"marketCap":67267162},{"date":"2022-05-27","current":-3.527801,"twenty":-88.60023,"median":-17.467267,"eighty":-9.097299,"marketCap":62462364},{"date":"2022-06-03","current":-3.744897,"twenty":-88.60023,"median":-17.373275,"eighty":-9.093511,"marketCap":66306202},{"date":"2022-06-10","current":-1.628216,"twenty":-88.60023,"median":-17.227608,"eighty":-8.989743,"marketCap":28828783},{"date":"2022-06-17","current":-1.764263,"twenty":-88.60023,"median":-17.146548,"eighty":-8.906096,"marketCap":31237588},{"date":"2022-06-24","current":-1.790857,"twenty":-88.60023,"median":-17.057037,"eighty":-8.85907,"marketCap":31708458},{"date":"2022-07-01","current":-1.82722,"twenty":-88.60023,"median":-17.057037,"eighty":-8.794971,"marketCap":32352301},{"date":"2022-07-08","current":-1.881494,"twenty":-88.60023,"median":-16.871014,"eighty":-8.794971,"marketCap":33313261},{"date":"2022-07-15","current":-1.415282,"twenty":-88.60023,"median":-16.641799,"eighty":-8.791309,"marketCap":25058619},{"date":"2022-07-22","current":-1.4189,"twenty":-88.60023,"median":-16.368319,"eighty":-8.790393,"marketCap":25122683},{"date":"2022-07-29","current":-1.175934,"twenty":-88.60023,"median":-16.201757,"eighty":-8.70552,"marketCap":20820788},{"date":"2022-08-05","current":-1.14735,"twenty":-88.60023,"median":-16.10474,"eighty":-8.638835,"marketCap":20314682},{"date":"2022-08-12","current":-1.212116,"twenty":-88.60023,"median":-15.910707,"eighty":-8.55118,"marketCap":21461427},{"date":"2022-08-19","current":-1.600085,"twenty":-88.60023,"median":-15.82702,"eighty":-8.491696,"marketCap":28150574},{"date":"2022-08-26","current":-1.546748,"twenty":-88.60023,"median":-15.82702,"eighty":-8.487276,"marketCap":27212221},{"date":"2022-09-02","current":-1.875961,"twenty":-88.60023,"median":-15.82702,"eighty":-8.487276,"marketCap":33004121},{"date":"2022-09-09","current":-2.023095,"twenty":-88.60023,"median":-15.82702,"eighty":-8.340059,"marketCap":35592680},{"date":"2022-09-16","current":-1.3426,"twenty":-88.60023,"median":-15.800641,"eighty":-8.303464,"marketCap":23620596},{"date":"2022-09-23","current":-1.680089,"twenty":-88.60023,"median":-15.762085,"eighty":-8.21272,"marketCap":29558103},{"date":"2022-09-30","current":-1.618476,"twenty":-88.60023,"median":-15.716674,"eighty":-8.036784,"marketCap":28474144},{"date":"2022-10-07","current":-1.626753,"twenty":-88.60023,"median":-15.610527,"eighty":-7.747849,"marketCap":28619750},{"date":"2022-10-14","current":-1.287424,"twenty":-88.60023,"median":-15.563236,"eighty":-7.670371,"marketCap":22649887},{"date":"2022-10-21","current":-1.324208,"twenty":-88.60023,"median":-15.563236,"eighty":-7.581872,"marketCap":23297027},{"date":"2022-10-28","current":-1.359888,"twenty":-88.60023,"median":-15.563236,"eighty":-7.479591,"marketCap":23924752},{"date":"2022-11-04","current":-1.348301,"twenty":-88.60023,"median":-15.563236,"eighty":-7.430234,"marketCap":23720903},{"date":"2022-11-11","current":-1.327151,"twenty":-88.60023,"median":-15.563236,"eighty":-7.386283,"marketCap":23348798},{"date":"2022-11-18","current":-1.231758,"twenty":-88.60023,"median":-15.563236,"eighty":-7.319625,"marketCap":24008880},{"date":"2022-11-25","current":-1.245038,"twenty":-88.60023,"median":-15.522641,"eighty":-7.302197,"marketCap":24267736},{"date":"2022-12-02","current":-1.269773,"twenty":-88.60023,"median":-15.497757,"eighty":-7.288183,"marketCap":24749855},{"date":"2022-12-09","current":-1.228438,"twenty":-88.60023,"median":-15.445794,"eighty":-7.272153,"marketCap":23944166},{"date":"2022-12-16","current":-1.162036,"twenty":-88.60023,"median":-15.329372,"eighty":-7.261532,"marketCap":22649887},{"date":"2022-12-23","current":-1.145435,"twenty":-88.60023,"median":-15.299453,"eighty":-7.226677,"marketCap":22326317},{"date":"2022-12-30","current":-1.037532,"twenty":-88.60023,"median":-15.199238,"eighty":-7.174394,"marketCap":20223113},{"date":"2023-01-06","current":-1.512141,"twenty":-88.133914,"median":-15.199238,"eighty":-7.100329,"marketCap":29473974},{"date":"2023-01-13","current":-1.435777,"twenty":-86.576754,"median":-15.134575,"eighty":-6.953369,"marketCap":27985521},{"date":"2023-01-20","current":-1.29484,"twenty":-85.538648,"median":-15.003998,"eighty":-6.821454,"marketCap":25238445},{"date":"2023-01-27","current":-1.261473,"twenty":-85.538648,"median":-14.852734,"eighty":-6.739858,"marketCap":24588070},{"date":"2023-02-03","current":-1.167182,"twenty":-85.538648,"median":-14.654339,"eighty":-6.646897,"marketCap":22750194},{"date":"2023-02-10","current":-1.245038,"twenty":-70.569383,"median":-14.475627,"eighty":-6.564425,"marketCap":24267736},{"date":"2023-02-17","current":-1.203539,"twenty":-70.569383,"median":-14.327911,"eighty":-6.471848,"marketCap":23458844},{"date":"2023-02-24","current":-1.161758,"twenty":-70.569383,"median":-14.296916,"eighty":-6.418638,"marketCap":22644477},{"date":"2023-03-03","current":-1.170116,"twenty":-70.569383,"median":-14.296916,"eighty":-6.368733,"marketCap":22807387},{"date":"2023-03-10","current":-0.98808,"twenty":-70.569383,"median":-14.296916,"eighty":-6.32741,"marketCap":19259209},{"date":"2023-03-17","current":-1.002957,"twenty":-70.569383,"median":-14.296916,"eighty":-6.222154,"marketCap":19549189},{"date":"2023-03-24","current":-1.019673,"twenty":-70.569383,"median":-14.118204,"eighty":-6.090777,"marketCap":19875009},{"date":"2023-03-31","current":-1.069821,"twenty":-70.569383,"median":-14.118204,"eighty":-5.965645,"marketCap":20852468},{"date":"2023-04-06","current":-1.043077,"twenty":-70.569383,"median":-14.066248,"eighty":-5.910288,"marketCap":20331189},{"date":"2023-04-14","current":-1.321345,"twenty":-64.954263,"median":-14.066248,"eighty":-5.744966,"marketCap":21700767},{"date":"2023-04-21","current":-1.310948,"twenty":-60.422571,"median":-13.83181,"eighty":-5.658826,"marketCap":21530015},{"date":"2023-04-28","current":-1.398249,"twenty":-47.962314,"median":-13.730013,"eighty":-5.59802,"marketCap":22963775},{"date":"2023-05-05","current":-1.498124,"twenty":-47.962314,"median":-13.705049,"eighty":-5.49939,"marketCap":24604044},{"date":"2023-05-12","current":-1.558049,"twenty":-47.962314,"median":-13.64563,"eighty":-5.24151,"marketCap":25588206},{"date":"2023-05-19","current":-1.963531,"twenty":-47.962314,"median":-13.355558,"eighty":-3.791935,"marketCap":24056194},{"date":"2023-05-26","current":-1.809834,"twenty":-47.962314,"median":-13.299333,"eighty":-3.683387,"marketCap":22173165},{"date":"2023-06-02","current":-1.797516,"twenty":-46.033619,"median":-13.23074,"eighty":-3.614639,"marketCap":22022260},{"date":"2023-06-09","current":-1.684251,"twenty":-43.485789,"median":-12.981103,"eighty":-3.299851,"marketCap":20634592},{"date":"2023-06-16","current":-1.609276,"twenty":-39.895803,"median":-12.731467,"eighty":-2.015739,"marketCap":19716041},{"date":"2023-06-23","current":-1.446742,"twenty":-38.369814,"median":-12.48183,"eighty":-1.965287,"marketCap":17724753},{"date":"2023-06-30","current":-1.344455,"twenty":-36.826895,"median":-12.48183,"eighty":-1.921295,"marketCap":16471587},{"date":"2023-07-07","current":-1.241901,"twenty":-36.397248,"median":-12.48183,"eighty":-1.877068,"marketCap":15215141},{"date":"2023-07-14","current":-1.204949,"twenty":-33.757987,"median":-12.48183,"eighty":-1.845821,"marketCap":14762426},{"date":"2023-07-21","current":-1.017513,"twenty":-33.635231,"median":-12.357585,"eighty":-1.824236,"marketCap":12466049},{"date":"2023-07-28","current":-0.905985,"twenty":-32.837315,"median":-12.357012,"eighty":-1.794379,"marketCap":11099674},{"date":"2023-08-04","current":-0.900255,"twenty":-31.425617,"median":-11.857738,"eighty":-1.773608,"marketCap":11029470},{"date":"2023-08-11","current":-0.63419,"twenty":-30.638859,"median":-11.386083,"eighty":-1.73785,"marketCap":7769771},{"date":"2023-08-18","current":-0.55807,"twenty":-30.103498,"median":-11.220378,"eighty":-1.68709,"marketCap":7062935},{"date":"2023-08-25","current":-0.523965,"twenty":-29.033151,"median":-11.097077,"eighty":-1.675707,"marketCap":6631311},{"date":"2023-09-01","current":-0.420938,"twenty":-28.224507,"median":-11.097077,"eighty":-1.659207,"marketCap":5327390},{"date":"2023-09-08","current":-0.350246,"twenty":-27.178685,"median":-11.097077,"eighty":-1.647519,"marketCap":4432713},{"date":"2023-09-15","current":-0.343819,"twenty":-25.922457,"median":-10.973777,"eighty":-1.629248,"marketCap":4351379},{"date":"2023-09-22","current":-0.313422,"twenty":-25.608909,"median":-10.850476,"eighty":-1.618329,"marketCap":3966668},{"date":"2023-09-29","current":-0.321326,"twenty":-23.64226,"median":-10.850476,"eighty":-1.601441,"marketCap":4066710},{"date":"2023-10-06","current":-0.289162,"twenty":-22.775869,"median":-10.688976,"eighty":-1.580196,"marketCap":3659632},{"date":"2023-10-13","current":-0.282767,"twenty":-22.573417,"median":-10.456607,"eighty":-1.555984,"marketCap":3578704},{"date":"2023-10-20","current":-0.29562,"twenty":-21.87715,"median":-10.357272,"eighty":-1.530122,"marketCap":3741373},{"date":"2023-10-27","current":-0.411298,"twenty":-20.708929,"median":-10.28233,"eighty":-1.525237,"marketCap":5205388},{"date":"2023-11-03","current":-0.385592,"twenty":-20.392025,"median":-10.008413,"eighty":-1.495062,"marketCap":4880052},{"date":"2023-11-10","current":-0.347032,"twenty":-20.25282,"median":-9.861161,"eighty":-1.453706,"marketCap":4392046},{"date":"2023-11-17","current":-0.527039,"twenty":-20.061981,"median":-9.742695,"eighty":-1.436505,"marketCap":6466068},{"date":"2023-11-24","current":-1.186185,"twenty":-20.052297,"median":-9.704796,"eighty":-1.418894,"marketCap":14552898},{"date":"2023-12-01","current":-0.739897,"twenty":-20.005723,"median":-9.704796,"eighty":-1.398059,"marketCap":9077550},{"date":"2023-12-08","current":-0.734025,"twenty":-19.855784,"median":-9.614269,"eighty":-1.379383,"marketCap":9005506},{"date":"2023-12-15","current":-0.757514,"twenty":-19.851774,"median":-9.529855,"eighty":-1.357844,"marketCap":9293682},{"date":"2023-12-22","current":-0.645942,"twenty":-19.450728,"median":-9.294762,"eighty":-1.3426,"marketCap":7924845},{"date":"2023-12-29","current":-0.734025,"twenty":-19.297293,"median":-9.178577,"eighty":-1.336307,"marketCap":9005506},{"date":"2024-01-05","current":-0.88681,"twenty":-18.799586,"median":-9.116636,"eighty":-1.327539,"marketCap":10879973},{"date":"2024-01-12","current":-0.924547,"twenty":-18.612428,"median":-9.098246,"eighty":-1.320866,"marketCap":11342950},{"date":"2024-01-19","current":-0.793298,"twenty":-18.4748,"median":-9.093511,"eighty":-1.311971,"marketCap":9732698},{"date":"2024-01-26","current":-0.812646,"twenty":-18.270731,"median":-8.999403,"eighty":-1.29484,"marketCap":9970081},{"date":"2024-02-02","current":-0.973886,"twenty":-18.114699,"median":-8.888116,"eighty":-1.287424,"marketCap":11948272},{"date":"2024-02-09","current":-0.838445,"twenty":-18.019487,"median":-8.794971,"eighty":-1.269673,"marketCap":10286591},{"date":"2024-02-16","current":-0.825545,"twenty":-17.817247,"median":-8.794971,"eighty":-1.256593,"marketCap":10128336},{"date":"2024-02-23","current":-0.780398,"twenty":-17.732346,"median":-8.790393,"eighty":-1.250053,"marketCap":9574443},{"date":"2024-03-01","current":-0.780398,"twenty":-17.646021,"median":-8.785645,"eighty":-1.245038,"marketCap":9574443},{"date":"2024-03-08","current":-0.806197,"twenty":-17.646021,"median":-8.666669,"eighty":-1.242787,"marketCap":9890953},{"date":"2024-03-15","current":-1.202078,"twenty":-17.560637,"median":-8.610667,"eighty":-1.232053,"marketCap":12640641},{"date":"2024-03-22","current":-1.061836,"twenty":-17.368294,"median":-8.491696,"eighty":-1.227587,"marketCap":11165900},{"date":"2024-03-28","current":-1.202078,"twenty":-17.227608,"median":-8.487276,"eighty":-1.21683,"marketCap":12640641},{"date":"2024-04-05","current":-1.282217,"twenty":-17.050112,"median":-8.393504,"eighty":-1.215841,"marketCap":13483351},{"date":"2024-04-12","current":-1.151992,"twenty":-16.459254,"median":-8.335718,"eighty":-1.212048,"marketCap":12113948},{"date":"2024-04-19","current":-1.051818,"twenty":-16.10474,"median":-8.21272,"eighty":-1.209834,"marketCap":11060561},{"date":"2024-04-26","current":-1.592754,"twenty":-15.910707,"median":-7.968666,"eighty":-1.204842,"marketCap":16748850},{"date":"2024-05-03","current":-1.151992,"twenty":-15.82702,"median":-7.731497,"eighty":-1.203538,"marketCap":12113948},{"date":"2024-05-10","current":-1.101905,"twenty":-15.82702,"median":-7.634408,"eighty":-1.200338,"marketCap":11587254},{"date":"2024-05-17","current":-1.061836,"twenty":-15.734838,"median":-7.48459,"eighty":-1.18456,"marketCap":11165900},{"date":"2024-05-24","current":-0.858149,"twenty":-15.582152,"median":-7.430234,"eighty":-1.178636,"marketCap":10834083},{"date":"2024-05-31","current":-0.715889,"twenty":-15.563236,"median":-7.382,"eighty":-1.173177,"marketCap":9038058},{"date":"2024-06-07","current":-0.658318,"twenty":-15.563236,"median":-7.319625,"eighty":-1.165754,"marketCap":8311221},{"date":"2024-06-14","current":-0.711685,"twenty":-15.563236,"median":-7.290579,"eighty":-1.161858,"marketCap":8984974},{"date":"2024-06-21","current":-0.630227,"twenty":-15.512687,"median":-7.276703,"eighty":-1.151992,"marketCap":7956573},{"date":"2024-06-28","current":-0.631856,"twenty":-15.351334,"median":-7.261532,"eighty":-1.146431,"marketCap":7977141},{"date":"2024-07-05","current":-0.62594,"twenty":-15.258759,"median":-7.232486,"eighty":-1.131572,"marketCap":7902447},{"date":"2024-07-12","current":-0.703024,"twenty":-15.199238,"median":-7.174394,"eighty":-1.12194,"marketCap":8875638},{"date":"2024-07-15","current":-0.678244,"twenty":-15.199238,"median":-7.116302,"eighty":-1.119798,"marketCap":8562788},{"date":"2024-08-02","current":-0.716281,"twenty":-14.887513,"median":-6.941989,"eighty":-1.109939,"marketCap":9043003},{"date":"2024-08-09","current":-0.651797,"twenty":-14.669052,"median":-6.792928,"eighty":-1.091888,"marketCap":8228892},{"date":"2024-08-16","current":-0.751707,"twenty":-14.498482,"median":-6.738702,"eighty":-1.08187,"marketCap":8549966},{"date":"2024-08-23","current":-0.748193,"twenty":-14.327911,"median":-6.622518,"eighty":-1.078179,"marketCap":8510005},{"date":"2024-08-30","current":-0.721532,"twenty":-14.296916,"median":-6.562136,"eighty":-1.072328,"marketCap":8206761},{"date":"2024-09-06","current":-0.68602,"twenty":-14.296916,"median":-6.469219,"eighty":-1.069821,"marketCap":7802835},{"date":"2024-09-13","current":-0.727328,"twenty":-14.296916,"median":-6.411345,"eighty":-1.061836,"marketCap":8272684},{"date":"2024-09-20","current":-0.696727,"twenty":-14.296916,"median":-6.353237,"eighty":-1.054133,"marketCap":7924624},{"date":"2024-09-27","current":-0.695504,"twenty":-14.296916,"median":-6.321565,"eighty":-1.044289,"marketCap":7910709},{"date":"2024-10-04","current":-0.671793,"twenty":-14.118204,"median":-6.222154,"eighty":-1.036389,"marketCap":7641025},{"date":"2024-10-11","current":-0.50013,"twenty":-14.066248,"median":-6.067323,"eighty":-1.01984,"marketCap":5688519},{"date":"2024-10-18","current":-0.576109,"twenty":-14.066248,"median":-5.964847,"eighty":-1.014835,"marketCap":6552704},{"date":"2024-10-25","current":-0.757678,"twenty":-13.83181,"median":-5.814279,"eighty":-0.991815,"marketCap":8617878},{"date":"2024-10-31","current":-0.758731,"twenty":-13.730013,"median":-5.719235,"eighty":-0.980335,"marketCap":8629864},{"date":"2024-11-08","current":-0.571578,"twenty":-13.730013,"median":-5.630104,"eighty":-0.95093,"marketCap":6501164},{"date":"2024-11-15","current":-0.58064,"twenty":-13.64563,"median":-5.578452,"eighty":-0.920835,"marketCap":6604243},{"date":"2024-11-22","current":-0.799583,"twenty":-13.418762,"median":-5.497016,"eighty":-0.900947,"marketCap":6591059},{"date":"2024-11-29","current":-0.787271,"twenty":-13.355558,"median":-5.239709,"eighty":-0.895748,"marketCap":6489564},{"date":"2024-12-06","current":-0.794995,"twenty":-13.233835,"median":-3.78108,"eighty":-0.88234,"marketCap":6553235},{"date":"2024-12-13","current":-0.764989,"twenty":-13.105921,"median":-3.672532,"eighty":-0.851444,"marketCap":6305897},{"date":"2024-12-20","current":-0.769,"twenty":-12.89,"median":-3.527801,"eighty":-0.838445,"marketCap":6338957},{"date":"2024-12-27","current":-0.830348,"twenty":-12.631501,"median":-3.093611,"eighty":-0.825442,"marketCap":6844653},{"date":"2025-01-03","current":-0.952598,"twenty":-12.48183,"median":-2.023095,"eighty":-0.825442,"marketCap":7852372},{"date":"2025-01-10","current":-0.793212,"twenty":-12.48183,"median":-1.965726,"eighty":-0.824584,"marketCap":6538542},{"date":"2025-01-17","current":-0.818613,"twenty":-12.48183,"median":-1.915211,"eighty":-0.816226,"marketCap":6747922},{"date":"2025-01-24","current":-0.79247,"twenty":-12.48183,"median":-1.86954,"eighty":-0.811335,"marketCap":6532419},{"date":"2025-01-31","current":-0.772417,"twenty":-12.48183,"median":-1.845312,"eighty":-0.806197,"marketCap":6367119},{"date":"2025-02-07","current":-0.680321,"twenty":-12.48183,"median":-1.822285,"eighty":-0.800781,"marketCap":5607963},{"date":"2025-02-14","current":-0.62239,"twenty":-12.48183,"median":-1.794164,"eighty":-0.798943,"marketCap":5130429},{"date":"2025-02-21","current":-0.868969,"twenty":-12.48183,"median":-1.774601,"eighty":-0.794876,"marketCap":7163009},{"date":"2025-02-28","current":-1.185362,"twenty":-12.48183,"median":-1.738663,"eighty":-0.794876,"marketCap":9771079},{"date":"2025-03-07","current":-0.94517,"twenty":-12.48183,"median":-1.686929,"eighty":-0.794817,"marketCap":7791150},{"date":"2025-03-14","current":-1.021967,"twenty":-12.48183,"median":-1.674611,"eighty":-0.794817,"marketCap":8424189},{"date":"2025-03-21","current":-0.987802,"twenty":-12.48183,"median":-1.658971,"eighty":-0.794817,"marketCap":8142566},{"date":"2025-03-28","current":-1.186848,"twenty":-12.48183,"median":-1.64007,"eighty":-0.794817,"marketCap":9783324},{"date":"2025-04-04","current":-1.358413,"twenty":-12.48183,"median":-1.633375,"eighty":-0.794817,"marketCap":11197559},{"date":"2025-04-11","current":-1.559687,"twenty":-12.48183,"median":-1.622615,"eighty":-0.794876,"marketCap":12856684},{"date":"2025-04-17","current":-2.422481,"twenty":-12.48183,"median":-1.616463,"eighty":-0.794876,"marketCap":11877127},{"date":"2025-04-25","current":-2.795995,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":13708421},{"date":"2025-05-02","current":-5.324769,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":15499093},{"date":"2025-05-09","current":-6.823976,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19862916},{"date":"2025-05-16","current":-6.668915,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19411570},{"date":"2025-05-23","current":-6.755518,"twenty":-12.48183,"median":-1.615552,"eighty":-0.794817,"marketCap":19663651},{"date":"2025-05-30","current":-7.816302,"twenty":-12.357356,"median":-1.615552,"eighty":-0.794817,"marketCap":22751332},{"date":"2025-06-06","current":-8.374609,"twenty":-12.307084,"median":-1.615552,"eighty":-0.794817,"marketCap":24376428},{"date":"2025-06-13","current":-10.328685,"twenty":-11.690443,"median":-1.615552,"eighty":-0.794817,"marketCap":30064261},{"date":"2025-06-20","current":-10.831161,"twenty":-11.321673,"median":-1.612414,"eighty":-0.794757,"marketCap":31526846},{"date":"2025-06-27","current":-12.22693,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":35589584},{"date":"2025-07-03","current":-17.363357,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":50540460},{"date":"2025-07-11","current":-18.703294,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":54440689},{"date":"2025-07-18","current":-19.987401,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":58178408},{"date":"2025-07-25","current":-18.144987,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":52815594},{"date":"2025-08-01","current":-13.399375,"twenty":-11.220378,"median":-1.612414,"eighty":-0.794757,"marketCap":39002284}],"updateTime":1754154892832}}}